Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07304531Recruiting

First To Know Pregnancy Test - Clinical Evaluation Protocol

Role: lead

NCT04690413Not ApplicableCompleted

NOWDx Test for the Detection of Antibodies to COVID-19

Role: lead

NCT04294030Withdrawn

NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2

Role: lead

NCT05063344Completed

NOWDx Test for the Diagnosis of Syphilis

Role: lead

NCT04799392Not ApplicableTerminated

NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons

Role: lead

All 5 trials loaded